You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雲南白藥(000538.SZ):中藥1類新藥全三七片獲批臨牀,治療心脈瘀阻所致的胸悶心痛等
格隆匯 03-03 11:59

格隆匯3月3日丨雲南白藥(000538.SZ)公佈,近日,公司收到國家藥監局核准籤關於全三七片的《藥物臨牀試驗批准通知書》,同意該藥品開展用於心脈瘀阻所致的胸悶心痛等的臨牀試驗。

全三七片的功能主治為活血散瘀,用於心脈瘀阻所致的胸悶心痛、心悸怔忡、失眠。目前市場上並沒有專門用於上述功能主治的中藥產品。

該項目是雲南省科技廳具體立項的重大科技專項,是中藥註冊分類改革後雲南白藥首個獲批臨牀的中藥1類新藥,也是雲南白藥擁有自主知識產權並獲批的第二個中醫證候類新藥。

截至目前,針對該產品已投入研發費用約人民幣1900萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account